Structure

Physi-Chem Properties

Molecular Weight:  430.31
Volume:  468.574
LogP:  4.317
LogD:  3.912
LogS:  -4.315
# Rotatable Bonds:  3
TPSA:  63.6
# H-Bond Aceptor:  4
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.59
Synthetic Accessibility Score:  4.856
Fsp3:  0.852
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.728
MDCK Permeability:  2.0835219402215444e-05
Pgp-inhibitor:  1.0
Pgp-substrate:  0.007
Human Intestinal Absorption (HIA):  0.002
20% Bioavailability (F20%):  0.961
30% Bioavailability (F30%):  0.978

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.556
Plasma Protein Binding (PPB):  86.45335388183594%
Volume Distribution (VD):  0.935
Pgp-substrate:  18.015892028808594%

ADMET: Metabolism

CYP1A2-inhibitor:  0.024
CYP1A2-substrate:  0.125
CYP2C19-inhibitor:  0.045
CYP2C19-substrate:  0.741
CYP2C9-inhibitor:  0.234
CYP2C9-substrate:  0.061
CYP2D6-inhibitor:  0.019
CYP2D6-substrate:  0.101
CYP3A4-inhibitor:  0.652
CYP3A4-substrate:  0.436

ADMET: Excretion

Clearance (CL):  4.696
Half-life (T1/2):  0.127

ADMET: Toxicity

hERG Blockers:  0.231
Human Hepatotoxicity (H-HT):  0.577
Drug-inuced Liver Injury (DILI):  0.106
AMES Toxicity:  0.015
Rat Oral Acute Toxicity:  0.956
Maximum Recommended Daily Dose:  0.971
Skin Sensitization:  0.942
Carcinogencity:  0.687
Eye Corrosion:  0.791
Eye Irritation:  0.314
Respiratory Toxicity:  0.978

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC95899

Natural Product ID:  NPC95899
Common Name*:   Flabelliferin B
IUPAC Name:   [(4aS,4bR,6S,6aR,9S,10aS,10bR,12aS)-8-acetyl-9-hydroxy-1,1,4a,6a,10b-pentamethyl-2,3,4,4b,5,6,9,10,10a,11,12,12a-dodecahydrochrysen-6-yl] acetate
Synonyms:   Flabelliferin B
Standard InCHIKey:  JBPWKIMADBDSID-QGERINELSA-N
Standard InCHI:  InChI=1S/C27H42O4/c1-16(28)18-15-27(7)21(13-19(18)30)26(6)12-9-20-24(3,4)10-8-11-25(20,5)22(26)14-23(27)31-17(2)29/h15,19-23,30H,8-14H2,1-7H3/t19-,20-,21-,22+,23-,25-,26-,27+/m0/s1
SMILES:  CC(=O)O[C@H]1C[C@H]2[C@@]([C@H]3[C@@]1(C)C=C(C(=O)C)[C@H](C3)O)(C)CC[C@@H]1[C@]2(C)CCCC1(C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2087231
PubChem CID:   66554038
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0000265] Carboxylic acids and derivatives
        • [CHEMONTID:0001093] Carboxylic acid derivatives
          • [CHEMONTID:0001238] Carboxylic acid esters

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO6368 Carteriospongia flabellifera Species Thorectidae Eukaryota n.a. South Pacific n.a. PMID[22834941]
NPO6368 Carteriospongia flabellifera Species Thorectidae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT386 Cell Line KM12 Homo sapiens IC50 < 10000.0 nM PMID[505140]
NPT407 Cell Line COLO 205 Homo sapiens IC50 < 10000.0 nM PMID[505140]
NPT386 Cell Line KM12 Homo sapiens IC50 = 18000.0 nM PMID[505140]
NPT407 Cell Line COLO 205 Homo sapiens IC50 = 20000.0 nM PMID[505140]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC95899 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9388 High Similarity NPC478057
0.9175 High Similarity NPC478056
0.8857 High Similarity NPC277769
0.8857 High Similarity NPC90952
0.8835 High Similarity NPC275539
0.8835 High Similarity NPC189075
0.8812 High Similarity NPC95585
0.8812 High Similarity NPC90177
0.8812 High Similarity NPC476889
0.8812 High Similarity NPC282233
0.8776 High Similarity NPC98874
0.8738 High Similarity NPC110496
0.8713 High Similarity NPC476890
0.8713 High Similarity NPC40918
0.87 High Similarity NPC471041
0.8687 High Similarity NPC26413
0.8687 High Similarity NPC89225
0.8679 High Similarity NPC4573
0.8673 High Similarity NPC148523
0.8673 High Similarity NPC474727
0.866 High Similarity NPC214756
0.866 High Similarity NPC272075
0.866 High Similarity NPC295643
0.8654 High Similarity NPC473483
0.8646 High Similarity NPC232202
0.8614 High Similarity NPC476888
0.8614 High Similarity NPC93744
0.86 High Similarity NPC316598
0.8598 High Similarity NPC472926
0.8586 High Similarity NPC167193
0.8586 High Similarity NPC472806
0.8586 High Similarity NPC202833
0.8571 High Similarity NPC47853
0.8571 High Similarity NPC31522
0.8571 High Similarity NPC74751
0.8558 High Similarity NPC475570
0.8558 High Similarity NPC472925
0.8557 High Similarity NPC145067
0.8557 High Similarity NPC4036
0.8557 High Similarity NPC233455
0.8557 High Similarity NPC158030
0.8557 High Similarity NPC65120
0.8532 High Similarity NPC134430
0.8529 High Similarity NPC165250
0.8529 High Similarity NPC136289
0.8515 High Similarity NPC251680
0.8515 High Similarity NPC476299
0.8515 High Similarity NPC474012
0.8515 High Similarity NPC306856
0.8515 High Similarity NPC117685
0.8505 High Similarity NPC194951
0.8505 High Similarity NPC12046
0.85 High Similarity NPC476879
0.85 High Similarity NPC320306
0.85 High Similarity NPC253826
0.85 High Similarity NPC476878
0.85 High Similarity NPC189880
0.85 High Similarity NPC108078
0.85 High Similarity NPC170131
0.8485 Intermediate Similarity NPC195715
0.8476 Intermediate Similarity NPC476802
0.8476 Intermediate Similarity NPC89171
0.8476 Intermediate Similarity NPC90946
0.8476 Intermediate Similarity NPC300614
0.8462 Intermediate Similarity NPC80566
0.8454 Intermediate Similarity NPC474728
0.8447 Intermediate Similarity NPC471208
0.8447 Intermediate Similarity NPC254202
0.8447 Intermediate Similarity NPC275583
0.8447 Intermediate Similarity NPC131366
0.8438 Intermediate Similarity NPC104560
0.8431 Intermediate Similarity NPC471412
0.8431 Intermediate Similarity NPC97435
0.8431 Intermediate Similarity NPC472924
0.8431 Intermediate Similarity NPC81530
0.8426 Intermediate Similarity NPC157441
0.8426 Intermediate Similarity NPC122056
0.8426 Intermediate Similarity NPC25909
0.8421 Intermediate Similarity NPC322159
0.8421 Intermediate Similarity NPC472986
0.8421 Intermediate Similarity NPC472985
0.8416 Intermediate Similarity NPC78427
0.8416 Intermediate Similarity NPC260149
0.8416 Intermediate Similarity NPC58942
0.8416 Intermediate Similarity NPC475876
0.8416 Intermediate Similarity NPC16911
0.8416 Intermediate Similarity NPC174663
0.8416 Intermediate Similarity NPC471966
0.8411 Intermediate Similarity NPC474315
0.84 Intermediate Similarity NPC7124
0.84 Intermediate Similarity NPC329910
0.84 Intermediate Similarity NPC134072
0.84 Intermediate Similarity NPC234993
0.84 Intermediate Similarity NPC242848
0.8393 Intermediate Similarity NPC67569
0.8384 Intermediate Similarity NPC209868
0.8384 Intermediate Similarity NPC474529
0.8384 Intermediate Similarity NPC78580
0.8384 Intermediate Similarity NPC23621
0.8384 Intermediate Similarity NPC469982
0.8384 Intermediate Similarity NPC184006
0.8384 Intermediate Similarity NPC159365
0.8384 Intermediate Similarity NPC91010
0.8384 Intermediate Similarity NPC119562
0.8384 Intermediate Similarity NPC279410
0.8378 Intermediate Similarity NPC473636
0.8378 Intermediate Similarity NPC77689
0.8367 Intermediate Similarity NPC155120
0.8367 Intermediate Similarity NPC324341
0.8367 Intermediate Similarity NPC282616
0.8367 Intermediate Similarity NPC966
0.8367 Intermediate Similarity NPC470590
0.8367 Intermediate Similarity NPC6255
0.8367 Intermediate Similarity NPC471588
0.8367 Intermediate Similarity NPC73457
0.8367 Intermediate Similarity NPC288833
0.8367 Intermediate Similarity NPC60755
0.8367 Intermediate Similarity NPC285184
0.8367 Intermediate Similarity NPC228784
0.8367 Intermediate Similarity NPC77099
0.8367 Intermediate Similarity NPC198054
0.8365 Intermediate Similarity NPC475036
0.8365 Intermediate Similarity NPC222161
0.8365 Intermediate Similarity NPC96268
0.8364 Intermediate Similarity NPC472927
0.8364 Intermediate Similarity NPC475809
0.8351 Intermediate Similarity NPC314727
0.8351 Intermediate Similarity NPC198664
0.8351 Intermediate Similarity NPC477973
0.8351 Intermediate Similarity NPC470588
0.8351 Intermediate Similarity NPC281524
0.8351 Intermediate Similarity NPC143232
0.8351 Intermediate Similarity NPC474700
0.8351 Intermediate Similarity NPC274330
0.835 Intermediate Similarity NPC293753
0.835 Intermediate Similarity NPC137430
0.8349 Intermediate Similarity NPC147912
0.8349 Intermediate Similarity NPC67259
0.8333 Intermediate Similarity NPC472972
0.8333 Intermediate Similarity NPC266955
0.8333 Intermediate Similarity NPC287676
0.8333 Intermediate Similarity NPC327431
0.8333 Intermediate Similarity NPC475156
0.8333 Intermediate Similarity NPC471413
0.8333 Intermediate Similarity NPC476767
0.8333 Intermediate Similarity NPC473576
0.8333 Intermediate Similarity NPC269530
0.8319 Intermediate Similarity NPC23786
0.8319 Intermediate Similarity NPC470265
0.8318 Intermediate Similarity NPC197428
0.8318 Intermediate Similarity NPC179642
0.8317 Intermediate Similarity NPC473456
0.8317 Intermediate Similarity NPC287668
0.8317 Intermediate Similarity NPC224356
0.8317 Intermediate Similarity NPC132753
0.8317 Intermediate Similarity NPC121402
0.8317 Intermediate Similarity NPC151681
0.8317 Intermediate Similarity NPC175351
0.8304 Intermediate Similarity NPC476962
0.8302 Intermediate Similarity NPC322903
0.8302 Intermediate Similarity NPC476765
0.8302 Intermediate Similarity NPC151393
0.8302 Intermediate Similarity NPC325054
0.83 Intermediate Similarity NPC470232
0.83 Intermediate Similarity NPC473240
0.83 Intermediate Similarity NPC23241
0.83 Intermediate Similarity NPC139570
0.83 Intermediate Similarity NPC470229
0.8288 Intermediate Similarity NPC251310
0.8288 Intermediate Similarity NPC21326
0.8286 Intermediate Similarity NPC231530
0.8286 Intermediate Similarity NPC111952
0.8286 Intermediate Similarity NPC278628
0.8283 Intermediate Similarity NPC86368
0.8283 Intermediate Similarity NPC298554
0.8283 Intermediate Similarity NPC151722
0.8283 Intermediate Similarity NPC199543
0.8273 Intermediate Similarity NPC268954
0.8273 Intermediate Similarity NPC44170
0.8269 Intermediate Similarity NPC159442
0.8269 Intermediate Similarity NPC72151
0.8269 Intermediate Similarity NPC99266
0.8269 Intermediate Similarity NPC8196
0.8265 Intermediate Similarity NPC120840
0.8265 Intermediate Similarity NPC86372
0.8265 Intermediate Similarity NPC470589
0.8265 Intermediate Similarity NPC126369
0.8265 Intermediate Similarity NPC172361
0.8265 Intermediate Similarity NPC111110
0.8265 Intermediate Similarity NPC291028
0.8265 Intermediate Similarity NPC113989
0.8257 Intermediate Similarity NPC159333
0.8252 Intermediate Similarity NPC163963
0.8252 Intermediate Similarity NPC52899
0.8252 Intermediate Similarity NPC282524
0.8252 Intermediate Similarity NPC115862
0.8252 Intermediate Similarity NPC115899
0.8252 Intermediate Similarity NPC289148
0.8247 Intermediate Similarity NPC48107
0.8247 Intermediate Similarity NPC474512

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC95899 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8571 High Similarity NPD7748 Approved
0.8557 High Similarity NPD7515 Phase 2
0.8515 High Similarity NPD7639 Approved
0.8515 High Similarity NPD7640 Approved
0.8416 Intermediate Similarity NPD7638 Approved
0.8317 Intermediate Similarity NPD7902 Approved
0.8198 Intermediate Similarity NPD7115 Discovery
0.802 Intermediate Similarity NPD7900 Approved
0.802 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7885 Intermediate Similarity NPD4225 Approved
0.783 Intermediate Similarity NPD7632 Discontinued
0.7745 Intermediate Similarity NPD5779 Approved
0.7745 Intermediate Similarity NPD5778 Approved
0.7745 Intermediate Similarity NPD6399 Phase 3
0.77 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7677 Intermediate Similarity NPD3618 Phase 1
0.7647 Intermediate Similarity NPD6079 Approved
0.7636 Intermediate Similarity NPD6881 Approved
0.7636 Intermediate Similarity NPD6899 Approved
0.7627 Intermediate Similarity NPD8328 Phase 3
0.7624 Intermediate Similarity NPD5328 Approved
0.7615 Intermediate Similarity NPD6675 Approved
0.7615 Intermediate Similarity NPD6402 Approved
0.7615 Intermediate Similarity NPD7128 Approved
0.7615 Intermediate Similarity NPD5739 Approved
0.76 Intermediate Similarity NPD3573 Approved
0.7545 Intermediate Similarity NPD5697 Approved
0.7521 Intermediate Similarity NPD6319 Approved
0.7521 Intermediate Similarity NPD7736 Approved
0.75 Intermediate Similarity NPD6684 Approved
0.75 Intermediate Similarity NPD7290 Approved
0.75 Intermediate Similarity NPD7334 Approved
0.75 Intermediate Similarity NPD7146 Approved
0.75 Intermediate Similarity NPD7521 Approved
0.75 Intermediate Similarity NPD6409 Approved
0.75 Intermediate Similarity NPD6883 Approved
0.75 Intermediate Similarity NPD7102 Approved
0.75 Intermediate Similarity NPD5330 Approved
0.7477 Intermediate Similarity NPD6011 Approved
0.7477 Intermediate Similarity NPD7320 Approved
0.7477 Intermediate Similarity NPD6686 Approved
0.7476 Intermediate Similarity NPD6411 Approved
0.7475 Intermediate Similarity NPD4786 Approved
0.7456 Intermediate Similarity NPD4632 Approved
0.7455 Intermediate Similarity NPD6008 Approved
0.7453 Intermediate Similarity NPD6083 Phase 2
0.7453 Intermediate Similarity NPD6084 Phase 2
0.7451 Intermediate Similarity NPD7285 Clinical (unspecified phase)
0.7449 Intermediate Similarity NPD3667 Approved
0.7434 Intermediate Similarity NPD6617 Approved
0.7434 Intermediate Similarity NPD6869 Approved
0.7434 Intermediate Similarity NPD6649 Approved
0.7434 Intermediate Similarity NPD6847 Approved
0.7434 Intermediate Similarity NPD8130 Phase 1
0.7434 Intermediate Similarity NPD6650 Approved
0.7417 Intermediate Similarity NPD7492 Approved
0.7411 Intermediate Similarity NPD6373 Approved
0.7411 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.7411 Intermediate Similarity NPD6372 Approved
0.7411 Intermediate Similarity NPD6014 Approved
0.7411 Intermediate Similarity NPD6013 Approved
0.7411 Intermediate Similarity NPD6012 Approved
0.74 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7387 Intermediate Similarity NPD6412 Phase 2
0.7387 Intermediate Similarity NPD5701 Approved
0.7373 Intermediate Similarity NPD6054 Approved
0.7368 Intermediate Similarity NPD6882 Approved
0.7368 Intermediate Similarity NPD8297 Approved
0.7358 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7358 Intermediate Similarity NPD5222 Approved
0.7358 Intermediate Similarity NPD5221 Approved
0.7355 Intermediate Similarity NPD6616 Approved
0.7353 Intermediate Similarity NPD6903 Approved
0.7353 Intermediate Similarity NPD6672 Approved
0.7353 Intermediate Similarity NPD5737 Approved
0.7339 Intermediate Similarity NPD5211 Phase 2
0.7327 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7317 Intermediate Similarity NPD7319 Approved
0.7308 Intermediate Similarity NPD8034 Phase 2
0.7308 Intermediate Similarity NPD8035 Phase 2
0.7308 Intermediate Similarity NPD7637 Suspended
0.73 Intermediate Similarity NPD3665 Phase 1
0.73 Intermediate Similarity NPD3133 Approved
0.73 Intermediate Similarity NPD3666 Approved
0.7295 Intermediate Similarity NPD7078 Approved
0.729 Intermediate Similarity NPD5173 Approved
0.7282 Intermediate Similarity NPD5764 Clinical (unspecified phase)
0.7282 Intermediate Similarity NPD6101 Approved
0.7281 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD4752 Clinical (unspecified phase)
0.7265 Intermediate Similarity NPD8295 Clinical (unspecified phase)
0.7265 Intermediate Similarity NPD6009 Approved
0.7257 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.725 Intermediate Similarity NPD6370 Approved
0.7245 Intermediate Similarity NPD4695 Discontinued
0.7238 Intermediate Similarity NPD4202 Approved
0.7228 Intermediate Similarity NPD1694 Approved
0.7227 Intermediate Similarity NPD6059 Approved
0.7213 Intermediate Similarity NPD7507 Approved
0.7212 Intermediate Similarity NPD5785 Approved
0.7207 Intermediate Similarity NPD5141 Approved
0.7196 Intermediate Similarity NPD4697 Phase 3
0.7193 Intermediate Similarity NPD5955 Clinical (unspecified phase)
0.7193 Intermediate Similarity NPD4634 Approved
0.719 Intermediate Similarity NPD7604 Phase 2
0.7179 Intermediate Similarity NPD6868 Approved
0.7168 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.7167 Intermediate Similarity NPD5983 Phase 2
0.7167 Intermediate Similarity NPD6015 Approved
0.7167 Intermediate Similarity NPD6016 Approved
0.7156 Intermediate Similarity NPD5285 Approved
0.7156 Intermediate Similarity NPD5286 Approved
0.7156 Intermediate Similarity NPD4696 Approved
0.7154 Intermediate Similarity NPD8293 Discontinued
0.7143 Intermediate Similarity NPD7645 Phase 2
0.713 Intermediate Similarity NPD4755 Approved
0.7107 Intermediate Similarity NPD5988 Approved
0.7103 Intermediate Similarity NPD5695 Phase 3
0.7103 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD5223 Approved
0.7073 Intermediate Similarity NPD6336 Discontinued
0.7064 Intermediate Similarity NPD5696 Approved
0.7059 Intermediate Similarity NPD5363 Approved
0.7059 Intermediate Similarity NPD6335 Approved
0.7043 Intermediate Similarity NPD6371 Approved
0.7037 Intermediate Similarity NPD7614 Phase 1
0.7034 Intermediate Similarity NPD6274 Approved
0.7027 Intermediate Similarity NPD5225 Approved
0.7027 Intermediate Similarity NPD5224 Approved
0.7027 Intermediate Similarity NPD4633 Approved
0.7027 Intermediate Similarity NPD5226 Approved
0.7 Intermediate Similarity NPD4700 Approved
0.7 Intermediate Similarity NPD7100 Approved
0.7 Intermediate Similarity NPD7101 Approved
0.699 Remote Similarity NPD4519 Discontinued
0.699 Remote Similarity NPD4623 Approved
0.6975 Remote Similarity NPD6317 Approved
0.6964 Remote Similarity NPD5175 Approved
0.6964 Remote Similarity NPD5174 Approved
0.6961 Remote Similarity NPD3668 Phase 3
0.6952 Remote Similarity NPD4753 Phase 2
0.6952 Remote Similarity NPD6904 Approved
0.6952 Remote Similarity NPD6673 Approved
0.6952 Remote Similarity NPD6080 Approved
0.6937 Remote Similarity NPD5344 Discontinued
0.693 Remote Similarity NPD5954 Clinical (unspecified phase)
0.6923 Remote Similarity NPD6053 Discontinued
0.6917 Remote Similarity NPD7328 Approved
0.6917 Remote Similarity NPD7327 Approved
0.6917 Remote Similarity NPD6313 Approved
0.6917 Remote Similarity NPD6314 Approved
0.6887 Remote Similarity NPD46 Approved
0.6887 Remote Similarity NPD6698 Approved
0.6885 Remote Similarity NPD8033 Approved
0.6881 Remote Similarity NPD7732 Phase 3
0.6869 Remote Similarity NPD6115 Approved
0.6869 Remote Similarity NPD6697 Approved
0.6869 Remote Similarity NPD6118 Approved
0.6869 Remote Similarity NPD6114 Approved
0.686 Remote Similarity NPD7516 Approved
0.6827 Remote Similarity NPD5279 Phase 3
0.6825 Remote Similarity NPD6033 Approved
0.6822 Remote Similarity NPD5693 Phase 1
0.6822 Remote Similarity NPD7983 Approved
0.6814 Remote Similarity NPD4754 Approved
0.6803 Remote Similarity NPD8377 Approved
0.6803 Remote Similarity NPD8294 Approved
0.6789 Remote Similarity NPD1698 Clinical (unspecified phase)
0.6789 Remote Similarity NPD4629 Approved
0.6789 Remote Similarity NPD5210 Approved
0.6774 Remote Similarity NPD6067 Discontinued
0.6765 Remote Similarity NPD4221 Approved
0.6765 Remote Similarity NPD4270 Approved
0.6765 Remote Similarity NPD4223 Phase 3
0.6765 Remote Similarity NPD4269 Approved
0.6748 Remote Similarity NPD8515 Approved
0.6748 Remote Similarity NPD8380 Approved
0.6748 Remote Similarity NPD8335 Approved
0.6748 Remote Similarity NPD8513 Phase 3
0.6748 Remote Similarity NPD6908 Approved
0.6748 Remote Similarity NPD6291 Clinical (unspecified phase)
0.6748 Remote Similarity NPD8379 Approved
0.6748 Remote Similarity NPD8296 Approved
0.6748 Remote Similarity NPD8517 Approved
0.6748 Remote Similarity NPD7503 Approved
0.6748 Remote Similarity NPD8516 Approved
0.6748 Remote Similarity NPD6909 Approved
0.6748 Remote Similarity NPD8378 Approved
0.6733 Remote Similarity NPD7525 Registered
0.6731 Remote Similarity NPD5329 Approved
0.6724 Remote Similarity NPD4730 Approved
0.6724 Remote Similarity NPD5168 Approved
0.6724 Remote Similarity NPD4729 Approved
0.6724 Remote Similarity NPD5128 Approved
0.6723 Remote Similarity NPD8133 Approved
0.67 Remote Similarity NPD5784 Clinical (unspecified phase)
0.6699 Remote Similarity NPD4788 Approved
0.6698 Remote Similarity NPD5208 Approved
0.6697 Remote Similarity NPD5282 Discontinued
0.6697 Remote Similarity NPD6001 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data